Market research
SEQUENT.NSE Sequent Scientific Limited
NSE INR Healthcare
Latest close
—
—
Loading market data…
Test a moving-average rule with historical data.
- Market cap
- 58B
- P/E ratio
- 199.83
- Analyst target
- 133.5
- Dividend yield
- Not available
- Beta
- 1.0
Community
Investor discussion
1 comment
Sign in to join the SEQUENT.NSE discussion.
5 years, 5 months ago
Sequent Scientific Limited is currently in a long term uptrend where the price is trading 26.3% above its 200 day moving average.
From a valuation standpoint, the stock is 6.0% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 4.5.
Sequent Scientific Limited's total revenue rose by 13.2% to $4B since the same quarter in the previous year.
Its net income has increased by 83.3% to $372M since the same quarter in the previous year.
Finally, its free cash flow grew by 203.1% to $843M since the same quarter in the previous year.
Based on the above factors, Sequent Scientific Limited gets an overall score of 5/5.